Jutaro Shudo joined Teikoku Pharma USA (TPU) in 2000. Dr. Shudo currently serves as Senior Vice President of Project Management & Planning / Scientific Affairs. Before joining TPU, Dr. Shudo worked at Teikoku Seiyaku Co., LTD as a topical and transdermal formulation scientist for the drug and cosmetic division. Dr. Shudo has been instrumental in the development of our chemotherapy drug and also headed the development of our Alzheimer drug in collaboration with Eisai. In his 30 year career, he has contributed to not only R&D, but Regulatory, Pre-clinical and Clinical efforts as well. His expertise also includes scale-up manufacturing. Dr. Shudo received a PhD in Pharmaceutical Science from Chiba University in Japan
